Life Sciences · Medical Device

Medical Device Contingent Workforce Solutions

Resource design history file remediation, EU MDR technical documentation, complaint backlogs, and verification and validation peaks without permanent headcount.

Medical device contingent workforce solutions address a demand pattern shaped by documentation rather than by production volume. Device organizations rarely need contract labor because manufacturing is busy; they need it because a design history file will not withstand review, because technical documentation for a legacy portfolio has to be rebuilt to EU MDR expectations, or because a complaint backlog has grown past what the quality team can clear. Viltis manages that work as a resourced program with the qualification and access controls the regulated environment requires.

Overview

The documentation backlog problem

Device companies carry a specific liability that pharma largely does not: a portfolio of legacy products whose documentation was adequate under the standards in force when they were cleared, and is not adequate now. The EU Medical Device Regulation made that visible at scale, and notified body capacity constraints made the timing worse.

The work itself is finite, document-heavy, and badly suited to permanent hiring: rebuilding clinical evaluation reports, reconstructing design rationale, closing gaps in risk management files, aligning post-market surveillance plans. It is the shape of work a contingent program handles well.

Overview

Roles device programs fill

Demand concentrates in a set of specializations that are hard to source from general staffing pools and are frequently needed in parallel across several product families at once.

  • Design history file remediation engineers and design assurance specialists

  • Regulatory writers for technical documentation, clinical evaluation reports, and submissions

  • Risk management specialists working to ISO 14971 across legacy and new product files

  • Verification and validation engineers, including test method validation and protocol execution

  • Complaint handling, medical device reporting, and vigilance specialists

  • Post-market surveillance and periodic safety update report authors

  • Software, cybersecurity, and interoperability specialists for connected devices

  • Sterilization, packaging, and biocompatibility support for portfolio transitions

Overview

Surge work with a defined end

Most device contract demand has a natural conclusion: the technical file is submitted, the backlog is cleared, the remediation commitment is closed. That makes it well suited to contract resourcing and poorly suited to permanent hiring, which is why device organizations that hire permanently against these peaks often end up restructuring within eighteen months.

The program treats them as projects with a staffing profile: capacity ramps, holds, and is released. That is a different thing from an indefinite headcount increase that has to be justified again each budget cycle.

Overview

Quality of output matters more than fill speed

A poorly written clinical evaluation report does not simply underperform; it generates notified body questions that cost more time than the document saved. Device programs therefore weight submittal quality and prior comparable experience far more heavily than time to fill.

We build supplier qualification and screening around that, including work-sample review for documentation-heavy roles, because a regulatory writer's previous technical files are a better predictor than their résumé.

Overview

Complaint handling and post-market capacity

Complaint and vigilance backlogs carry direct regulatory exposure, and they grow fastest at the worst moment: after a field action, a recall, or a launch that generates more feedback than anyone forecast.

These roles need people who can triage and document consistently under volume, and they need access to complaint systems that is provisioned quickly and revoked cleanly. The program handles both, and reports on backlog burn-down so capacity decisions rest on trend data rather than on how the team feels about the queue.

Benefits

What device organizations get

  • Remediation resourced as a project

    Documentation backlogs get a staffing profile with a ramp, a plateau, and a release, instead of becoming a permanent headcount argument.

  • Writers with comparable file experience

    Screening emphasizes prior technical documentation work and work samples, because output quality drives notified body cycles more than fill speed does.

  • Parallel capacity across product families

    Several product lines can be remediated concurrently rather than sequentially, which is usually the difference between meeting and missing a transition deadline.

  • Complaint backlogs with visible burn-down

    Vigilance and complaint capacity is tracked against queue trend, so staffing decisions are made on data rather than on escalation.

  • Access provisioned and revoked cleanly

    Complaint, CAPA, and document management access is scoped to the assignment and closed at its end, which matters when surge teams are large.

  • Specialist suppliers preserved

    Niche suppliers who reach real ISO 14971, sterilization, or device software talent are protected in the tier structure instead of being lost in a consolidation.

FAQ

Medical device contingent workforce FAQs

Can contractors author technical documentation for regulatory submission?

Yes, and it is common practice. The documentation remains your organization's, subject to your review and approval process. What the program adds is qualification evidence for the authors and consistent access control over the systems the documents live in.

How do you screen regulatory writers effectively?

Résumés are weak predictors for documentation roles. We use work-sample review, targeted technical screening against the specific device class and regulation involved, and supplier accountability for submittal quality measured over time.

Can you resource remediation across several product families at once?

Yes, and running them in parallel is usually the point. It needs a supplier base with real depth behind it, not one agency's bench, which is what supplier tiering is there to produce.

What happens to contractors when a remediation project ends?

Assignments close on the planned end date with access revoked and records retained. Strong performers are added to the direct sourcing pool, which materially shortens ramp-up when the next transition or backlog appears.

Do you support ISO 13485 quality system work as well as product documentation?

Yes. Quality system remediation, internal audit programs, supplier quality, and CAPA capacity are all within scope, and they frequently run alongside product documentation work after an audit finding.

Ready to talk through your program?

Bring us your current spend, supplier list, and compliance obligations. We will show you what a technology-enabled contingent workforce program would look like for your organization.